Thursday, 13 June 2019

Porcine Vaccines Market to Exhibit a CAGR of 7.1 % Forecast to 2022 | Global size, Share, Analysis and Trends

Market Highlights
The global porcine vaccines market held a market value of USD 1910.7 million in 2017 and is projected to grow at a CAGR of 7.1% over the forecast period. Porcine vaccines aid the swine or hogs suffering from epidemic swine diseases. It also helps in improving overall efficiency in protecting swine from deadly viruses, bacteria and increases the production level of high-quality meat and gelatine. The increasing prevalence of swine diseases such as PED (Porcine Epidemic Diarrhea), PRRS (Porcine Reproductive & Respiratory Syndrome), swine influenza etc. are anticipated to drive the market growth during the forecast period.  Additionally, rising number of biotechnology companies, research institutions engaged in research and development of porcine vaccines, and government initiatives for funding agriculture and animal husbandry sector and increasing demand for porcine meat and gelatine are likely to contribute to the market growth. For instance, by the world by per-capita pig meat consumption, US has an average of 64.4 kilos of meat consumed in 2017. According to National Pork Producers Council the pork production has an estimated USD 23.4 billion of gross output nationwide. However, high cost of maintaining vaccines may hamper the market growth during the assessment period.

Regional Analysis
On regional basis, the Americas is anticipated to dominate the global porcine vaccines market owing to the increasing prevalence of porcine diseases such as PED (Porcine Epidemic Diarrhea), PRRS (Porcine Reproductive & Respiratory Syndrome), swine influenza etc. and rapid increase in pig farms.  Additionally, rise in number of contract farming and independent farming for pig cultivation is contributing the market growth. According to The United States Department of Agriculture, National Agricultural Statistics Service “Livestock Slaughter” report, U.S. pork production was around 2 billion pound in 2016. Europe is expected to hold the second largest position in the global porcine vaccines market owing to increasing number of production units for pigs and high consumption of pork meat. The Asia-Pacific region is anticipated to be fastest growing region is due to introduction of new vaccines, initiatives by various government agencies, animal care associations, and incidence of major key players for growth and development in this region. The Middle East & Africa has the least share of the global porcine vaccines market. Moreover, the major market share of the region is expected to be held by the Middle East region owing to the increasing government initiatives for the agriculture and animal husbandry sector.

Segmentation
The global porcine vaccines market has been segmented into type, disease indication, and end user.
By type, the market has been segmented into Inactivated vaccines, Live attenuated vaccines, Toxoid vaccines, Recombinant vaccines, Conjugate vaccines, DNA vaccines.
On the basis of disease indication, the global porcine vaccines market has been segmented into PED (Porcine Epidemic Diarrhea), PRRS (Porcine Reproductive & Respiratory Syndrome), Swine influenza, Aujeszky's disease (AD), Porcine Circovirus Associated Disease (PCVAD) and others.
The global porcine vaccines market, by end user, has been segmented into Veterinary Hospitals and Hog Production Farm.

Key Players
Some of the prominent players in the global porcine vaccines market are Bayer AG, Bimeda, Inc., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Eli Lilly and Company, Merck & Co., Inc., Sanofi S.A., Vetoquinol S.A., Zoetis, Inc., PBS Animal Health, Aptimmune.

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels: ,
Location: Pune, Maharashtra, India

Thursday, 6 June 2019

Medical TelemetryMarket Analysis Revealing Key Drivers, Growth Trends and Competitive Analysis through 2024

Market Highlights
It is estimated that the global medical telemetry market is expected to register a CAGR ~21% during the forecast period of 2019 to 2024. 
"Medical Telemetry Market Research Report—Global Forecast till 2024 " Free Sample Copy Available @ https://www.marketresearchfuture.com/sample_request/7835
The global medical telemetry market is expected to witness tremendous growth owing to the information and communication technology or ICT, advancement in mobile perforation, and connectivity in the region is driving the growth of the medical telemetry market. Other factors such as the advent of various new-age facilities such as mHealth, virtual visits, and tele-ICUs. The industry players such as InTouch Health, iRobot, and Vecna Technologies have developed robots that serve as the physician's stand-in in remote clinics, which are the key factor driving the growth of the segment. However, factors such as low awareness about telemetry in the emerging region are expected to curb the growth of the market during the forecast period.
On a regional basis, the medical telemetry market in the Americas is predicted to dominate the market during the forecast period. The North American region holds a substantial share in the global market. This owes to the favorable government framework, high adoption of telehealth devices, and high acceptance rates of telemedicine by the patients in the region are driving the growth of the North America medical telemetry market. Emerging economies with growing healthcare expenditures are also expected to provide opportunities for the growth of the market. In addition to this, increasing government support and funding for the development and improving technology have fueled the growth of the market.
Currently, the medical telemetry market is dominated by numerous players. The number of manufacturers involved in the development of better devices. For instance, in July 2017, a wireless medical technology provider BioTelemetry Inc. completes acquisition of LifeWatch AG; healthcare technology solution provider. The objective of this acquisition is to capture a huge market opportunity for healthcare and associated domains.
The global medical telemetry market is segmented on the basis of component, service, application, and end user.
Access Full Report @ https://www.marketresearchfuture.com/reports/medical-telemetry-market-7835
The major players operating in the global medical telemetry market are Siemens AG, GE Healthcare, Astro-Med, Inc., Philips Healthcare, Lindsay Corporation, Honeywell International Inc., IBM Corp, Finmeccanica SPA. Medtronic, BioTelemetry Inc., Applied Cardiac Systems, Inc, Medicomp Inc, Preventice Services, LLC, The Scottcare Corporation, Medi-Lynx (Subsidiary of Medicalgorithmics, S.A), Zoll Medical Corporation, Welch Allyn, and Telerhythmics, LLC is occupying a considerable share of the market owing to their offerings to the market

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Posted by at No comments:
Labels: , , , ,

Hepatitis B Treatment Market to Record a CAGR of Approx 5.3% During 2018-2024

Market Highlights
The global hepatitis B treatment market is expected to grow at an approximate CAGR of 5.3% during the forecast period, 2018–2024.Hepatitis B is a viral infection caused by a hepatitis B virus. This infection lasts for a longer period and can cause many other complications, such as scarring in the liver, liver cancer or liver failure. The person suffering from hepatitis B faces various symptoms such as fever, fatigue, nausea, and muscle aches. The other symptoms include jaundice, swelling in the legs, poor appetite, drowsiness and many more. The key factors contributing the market growth are growing geriatric population, increasing the prevalence of viral infection and growing sexually transmitted diseases among the population contribute to driving the market growth. The World Hepatitis Alliance (WHA), 2017 reported that 52 million children across the world are living with viral hepatitis. Such a huge population suffering from Hepatitis boosts the market growth.However, the factor such as the side effects or complication caused due to treatment may hamper the market growth. 
Segmentation
The global hepatitis B treatment market is segmented on the basis of type, treatment, distribution channel, and region.
Based on type, the market is segmented into acute and chronic. On the basis of treatment, the global hepatitis B treatment market is segmented into immune modulator drugs, antiviral drugs, vaccine, and surgery  (liver transplant). The immune modulator drugs are further sub-segmented into pegylated interferon and interferon alpha. The antiviral drugs are sub-segmented into tenofovir disoproxil, entecavir, telbivudine, lamivudine, and others. By distribution channel, the market is segmented into hospital & retail pharmacies and online pharmacies.
Regional Analysis
The Americas dominates the global market for hepatitis B treatment. Factors such as the presence of a large number of healthcare companies, increasing geriatric population and high healthcare expenditure among the population within the Americas drives the market.The National Vaccine Information Center reported 3,370 cases of hepatitis B were reported in the US in 2015.
Following similar trends, Europe stood second in the global hepatitis B treatment market. The increased prevalence of viral diseases and growing healthcare expenditure in this region boost market growth. Also, the presence of developed economies, increasing healthcare facilities, and rising government funding for healthcare boost market growth. Asia Pacific was the fastest growing region for the global hepatitis B treatment market in 2017. This can be attributed due to the increasing incidences of HIV infection and rising demand for the treatment of viral infection among the population boosts market growth. 
On the other hand, the Middle East and Africa holds the least share in the global hepatitis B treatment market. The poor economies within the African region and lack of awareness about the treatment methods hinder the market growth.

Access Report Details @ https://www.marketresearchfuture.com/reports/hepatitis-b-treatment-market-7817
Key Players
Some of the key players in the global hepatitis B treatment market are Accord Healthcare Inc., Apotex Corp., Arbutus Biopharma, Arrowhead Pharma, Aurobindo Pharma Limited, Bristol-Myers Squibb Company, Gilead Sciences, Inc., GlaxoSmithKline, Lupin Pharmaceuticals, Inc., Merck & Co., Inc., Par Pharmaceutical, Inc., Teva Pharmaceuticals, Zydus Pharmaceuticals, and others.
Intended Audience
  • Pharmaceutical Companies
  • Biotechnological Institutes
  • Government and Private Laboratories
  • Research and Development (R&D) companies
  • Medical Research Laboratories
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Posted by at No comments:
Labels: , , , ,

Tuesday, 4 June 2019

Aseptic Sampling Market to Witness Surge in Demand Owing to Rising End-use Adoption

Aseptic Sampling Market – Overview
The booming biopharmaceutical industry is a key factor driving the demand for the aseptic sampling market. Market reports connected with the healthcare industry are being offered by Market Research Future which creates reports on other business verticals that defines the present market scenarios. The market is projected to advance with a formidable CAGR of 14.5% in the duration of the forecast period.
The escalating usage and implementation of single-use aseptic sampling systems are powering the expansion of the market. Furthermore, the progressing nature of process efficiency and reduction in the risk of product contamination is anticipated to motivate the expansion of the aseptic sampling market in the coming years.
Segmental Analysis
The segmentation of the aseptic sampling market comprises of application, type, technique, region, and end-user. The segmentation of the aseptic sampling market has been on the basis of type comprises of automated aseptic sampling and manual aseptic sampling. The aseptic sampling market segmentation by technique comprises of on-line sampling, off-line sampling technique, and at-line sampling. On the basis of application, the market has been segmented into downstream process and upstream process. Based on end-user, the aseptic sampling market has been segmented into research and development institutes, pharmaceutical and biotechnology companies, and contract research and manufacturing organizations. The regional basis of segmenting the aseptic sampling market comprises of the Asia Pacific, Americas, Europe, Africa, and the Middle East.
Detailed Regional Analysis
The regional analysis of the aseptic sampling market includes regions such as the Asia Pacific, Americas, Europe, Africa, and the Middle East. The European region is predicted to rule the aseptic sampling market globally. The market development in this region is accredited to the growing R&D activities and the budding biopharmaceutical sector. Furthermore, the governments in numerous European countries are backing pharmaceutical companies to unveil new biopharmaceutical products. This factor is anticipated to add to the development of the market. The Americas region is projected to be the next principal market in aseptic sampling owing to the stringent government regulations on safety and quality of pharmaceutical products and the incidence of a steady healthcare system.
Furthermore, the growing government spending for the healthcare sector is projected to back the market development in this region. The Asia Pacific region is projected to be the fastest rising market due to the mounting developments in healthcare infrastructure and increasing number of regional expansions by multinational biopharmaceutical companies. The Middle Eastern and African region is projected to be responsible for the least market share in the aseptic sampling market owing to the subdued development, the absence of technical knowledge, and weak medical facilities in emerging economies in this region.

Access Report @ https://www.marketresearchfuture.com/reports/aseptic-sampling-market-6282 
Competitive Analysis
Improved accessibility to diverse resources and capabilities is expected to impel the growth of the market in the coming forecast period. The use of effective strategy execution techniques is anticipated to bear positively on the future growth of the market. Furthermore, the vertical integrations and product strategies of the market is increasing the potential for the market players. The players in the market are attempting to create several leaderships that will allow them to secure a more substantial portion of the market. Product differentiation has formed a favorable product differentiation situation that is adding to the market’s progress. The analysis of the market states that it is poised for an increased growth rate in the forthcoming years.
The main competitors in the aseptic sampling market globally are Sartorius Stedim Biotech, Qualitru Sampling Systems, Thermo Fisher Scientific, Danaher Corporation, Flownamics Analytical Instruments, Saint Gobain, GEA Group, Merck KGaA, Keofitt, Gemü Group, W. L. Gore & Associates, Lonza Group, Trace Analytics, and Bürkle GmbH.
Industry Updates:
Feb 2018 CSP Technologies and QualiTru Sampling Systems have created TruDraw, a single-use aseptic sampling system for liquid dairy products. The sampler includes a tamper-evident feature and is a sterilized, sealed container with a sterile needle connected to draw a sample in, shielding against the risk of external adulteration.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
 Contact:
Market Research Future
+1 646 845 9312
Posted by at No comments:
Labels: , ,

Cord Blood Banking Services Market 2019 – Latest Industry Trends, Expert Survey, Analysis And Forecast To 2023

Overview:
The global cord blood banking services market is expected to exhibit a robust 11.4% CAGR over the forecast period from 2017 to 2023, according to a new report from Market Research Future (MRFR). The global cord blood baking services market is likely to be driven by the growing research into the medical utility of stem cells and cord blood, and the growing establishment of the infrastructure required to create a strong cord blood banking services network.
The growing realization of the utility of stem cells in treating a number of metabolic, immune, and blood disorders is likely to be a major driver for the global cord blood banking services market over the forecast period. Stem cells retain the basic genetic structure of an individual in the form of pluripotent cells that can be turned into a wide variety of cell types within the human body. This has made them highly important in the research field of diseases such as blood-related diseases, immune system diseases, cancers, and metabolic disorders. Cord blood banking remains the most effective way of acquiring, storing, and harnessing stem cells, making the cord blood banking services market likely to grow over the forecast period.
The rising government support to the cord blood banking services sector and increasing private investment in the field are also likely to be vital for the global cord blood banking services market over the forecast period. Due to the fragile and perishable nature of cord blood and stem cells, adequate storage infrastructure has to be put in place before efforts are made to retrieve and acquire stem cells from cord blood. Like regular blood, cord blood and stem cells also require significant efforts in terms of refrigeration and hygiene in order to maintain the stem cells in a viable form. The growing government support to expansion of the healthcare sector and increase in the adoption of and research into stem cells is likely to be a major driver for the global cord blood banking services market over the forecast period.
Segmentation:
The global cord blood banking services market has been segmented on the basis of storage service, component, application, end user, and region.
On the basis of storage service, the global cord blood banking services market is segmented into public cord blood banks, private cord blood banks, and hybrid cord blood banks.
On the basis of component, the global cord blood banking services market is segmented into cord blood, cord tissue, placenta, and others.
On the basis of application, the global cord blood banking services market is segmented into cancers, blood disorders, metabolic disorders, immune disorders, and osteoporosis.
On the basis of end user, the global cord blood banking services market is segmented into hospitals, pharmaceutical research, research institutes, and others.
Regional Analysis:
The global cord blood banking services market is segmented by region into the Americas, Europe, Asia Pacific, and the Middle East and Africa.
The Americas, followed by Europe, is expected to retain the dominant share in the global cord blood banking services market over the forecast period due to the widespread adoption of cord blood banking services in the region. Research efforts in the use of stem cells for medical purposes are also rife in the region, leading to strong growth prospects for the cord blood banking services market in the region. The increasing awareness about the utility of stem cells in treating a wide range of disorders in North America is also likely to be a major driver for the cord blood banking services market in the Americas over the forecast period. Europe is also likely to retain a significant share in the global cord blood banking services market over the forecast period due to the growing use of stem cells in medical applications and growth in the related infrastructure.
Competitive Analysis:
Leading players in the global cord blood banking services market include China Cord Blood Corporation, CBR Systems Inc., Virgin Health Bank, Vita 34 International, Stem Cell Cryobank Inc., and Americord Registry.
Industry Updates:
In January 2019, Cellular Engineering Technologies and the John Paul II Medical Research Institute, along with the University of Iowa, announced success in their efforts to create pluripotent stem cells safely from cord blood obtained from donors.
TABLE OF CONTENT
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Posted by at No comments:
Labels: , , ,

Thursday, 30 May 2019

Multiple Sclerosis Treatment Market to Perceive a Substantial Growth with approx. 3.5% CAGR during 2017-2023; MRFR Unleashes Insights up to 2023

Market Synopsis
Market Research Future postulates that the global multiple sclerosis treatment market is estimated to demonstrate 3.5% CAGR throughout the forecast period (2017-2023). Factors such as increasing patient pool and screening for better treatment options are likely to favor the market growth worldwide. Multiple sclerosis is referred to as an inflammatory, chronic, and an autoimmune disease which generally affects the central nervous system. It especially affects the communication between the brain and other body parts. Multiple sclerosis is a demyelinating disease in which the insulating covers of the nerve cells in the spinal cord and brain are damaged.
Get a FREE Sample Report with Complete TOC @ https://www.marketresearchfuture.com/sample_request/940
Market Potential and Pitfalls
Multiple sclerosis treatment market is anticipated to expand at a healthy CAGR throughout the forecast period owing to several driving factors. With augmenting patient population across the world and the need for better treatment options and greater screening, the market for multiple sclerosis treatment is estimated to flourish. As the aging population is more susceptible to the disease, the market is flourishing with the increasing geriatric population. Research and development activities are also considered to yield benefits with huge gain for the market. For instance, the introduction of a new drug with partial curing rate is expected to be welcomed by the market with minimum marketing efforts and cost. Such efforts are estimated to contribute to the market growth. Furthermore, with the augmenting incidences of muscle weakness, the market is likely to flourish in the coming years. Additional factor promoting the market growth is the presence of high unmet clinical requirements, especially in the developing economies. Organizations across the globe are spreading awareness related to progressive multiple sclerosis coupled with the symptoms associated with it, which is further estimated to propel the market growth. With reimbursement programs, the penetration of multiple sclerosis drugs is also likely to augment, thereby contributing to the market growth.
On the contrary, a significant gap between the early diagnosis and actual initiation of the therapy is likely to remain a major concern impeding the market growth to a great extent. Additionally, lack of cure and effective treatment is considered as one of the major drawbacks of the current treatment scenario. The high cost of the treatment is also presumed to impede the market growth to a large extent.

Browse Complete Report with Niche Segments and Top Industry Players at https://www.marketresearchfuture.com/reports/multiple-sclerosis-treatment-market-940
Global Multiple Sclerosis Treatment Market: Segmental Analysis
The global multiple sclerosis treatment market has been segmented on the basis of drug type, route of administration, diagnosis, and end-users.
By mode of drug type, the global multiple sclerosis treatment market has been segmented into immunosuppressant, immunomodulators, and others.
By mode of the route of administration, the global multiple sclerosis treatment market has been segmented into oral, injectable, and others.
By mode of diagnosis, the global multiple sclerosis treatment market has been segmented into simple electrical stimulation tests, magnetic resonance imaging (MRI) scans, lumbar puncture and others.
By mode of end-users, the global multiple sclerosis treatment market has been segmented into clinics, hospitals, and others.
Regional Insights
Geographically, the multiple sclerosis treatment market spans across regions namely, America, Asia Pacific, Europe, and the Middle East & Africa.
Among all the regions, America is considered to occupy the largest market share owing to the presence of U.K. in this region. U.S. is estimated to dominate the market due to the increasing R&D activities for better treatment of the disease and extensive development in the medical sector. An increasing number of hospitalization procedures owing to healthcare penetration in Canada and the U.S. are estimated to propel the market growth. Additional factors influencing the market growth are the high concentration of key hospitals and good reimbursement rates.
European is presumed to occupy the second largest market share and is likely to retain its dominance over the years. The growth is credited to the augmenting healthcare industry along with healthcare penetration. The region is mainly led by economies like France and Germany, where Germany is considered to be the fastest growing region due to the presence of its large pharmaceutical industry.
The Asia Pacific is anticipated to expand at a rapid pace and is presumed to lead the market owing to the large unmet needs coupled with the fast-developing healthcare sector in this region. South East Asian economies like India, China, and Malaysia highly contribute to the market growth. Additionally, penetration of the healthcare sector is likely to fuel the future multiple sclerosis market.
Industry Updates
January 16, 2019: In a clinical trial of Northwestern University Feinberg School of Medicine, researchers had found that while most of the patients on standard therapy were showing progression, the vast majority of patients who already underwent the stem cell transplant did not. An experimental treatment which was conducted for multiple sclerosis is now showing promise. A new study had found that a single stem cell transplant delays or stop the symptoms better than some medications.
Competitive Dashboard
The prominent players operating the global multiple sclerosis treatment market are Pfizer Inc. (U.S.), AbbVie (U.S.), Teva Pharmaceuticals (Israel), Merck (U.S.), Bayer Healthcare (Germany), Novartis (Switzerland), Sanofi Aventis (France), and Biogen Idec (U.S.).
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels: ,

Flow Cytometryt Market Size is Register at 11.5% CAGR to Reach by 2023


Flow Cytometry Market in diagnostics and increasing applications of flow cytometry in pharmaceutical research and development are the major factors driving the growth of the global flow cytometry market. Additionally, increasing R&D spending and aggressive strategies adopted by the top players, such as new product launches, are contributing to the growth of the market.
Flow Cytometry Market by increasing applications in healthcare along with the increasing number of cancer cases is projected to boost the market growth at a healthy CAGR of ~ 11.5 %.

For instance, in January 2016, Sysmex America Inc. has introduced New CyFlow monoclonal antibodies in the market, this new reagent was introduced in the American market which will be available for use in academic as well as clinical research and commercial manufacturing.

The global flow cytometry market has been segmented on the basis of products & services, technology, application, and end-user.
On the basis of products & services, the market has been classified as reagents and consumables, flow cytometry instruments, services, software, and accessories. The flow cytometry instruments segment has been further divided into cell analyzers and cell sorters.
Avail Sample Copy of this Report at: https://www.marketresearchfuture.com/sample_request/6433
The market by technology has been divided into cell-based flow cytometry and bead-based flow cytometry.
 The application segment has been divided into research applications, clinical applications, and industrial applications. The research applications segment has been segmented into pharmaceutical and biotechnology and immunology. The pharmaceutical and biotechnology sub-segment has been divided into drug discovery, stem cell research, and in vitro toxicity testing.
Furthermore, the immunology segment has been sub-segmented into cell sorting, apoptosis, cell cycle analysis, cell viability, cell counting, and other research applications. The clinical applications segment includes cancer, hematology, immunodeficiency diseases, organ transplantation, and other clinical applications.
Geographical Segmentation by Regions are as follows, Americas is expected to dominate the global flow cytometry market during the forecast period owing to the technological advancement, increasing prevalence of autoimmune diseases, and well-established healthcare sector in the region. The European market is expected to be the second-largest due to the increasing number of cancer patients in the region and government funding and support of the healthcare sector.
Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the forecast period owing to increasing awareness about healthcare, increasing research and development activities and favorable government initiatives for the establishment of healthcare facilities. The market in the Middle East & Africa is likely to account for the smallest share of the global flow cytometry market.
Some of the key players in the flow cytometry are Beckman Coulter, Inc., Becton, Dickinson and Company., Danaher., Thermo Fisher Scientific, Merck KGaA, Bio-Rad Laboratories, Inc., Luminex Corporation., Miltenyi Biotec, Sysmex Partec GmbH Agilent Technologies, Inc., Sony Corporation, Biomérieux S.A., and Enzo Biochem Inc.
The high costs associated with flow cytometry instruments and reagents, lack of awareness about applications of flow cytometry and a shortage of technicians may hamper the growth of the market during the assessment period.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Market Research Future
+1 646 845 9312


Posted by at No comments:
Labels: , , , ,
Subscribe to: Posts (Atom)